Insider filing · ARWR
Adeoye Y Olukotun
Director
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Adeoye Y Olukotun sold $620K of Arrowhead Pharmaceuticals (ARWR)
Executed Dec 19 2025, disclosed Dec 23 2025, 4 days later.
Value, as filed
$620K
9,173 sh across 2 lots
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 23 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AOAdeoye Y Olukotun (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $620K of ARWR (9,173 sh across 2 lots, as filed), executed Dec 19 2025.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adeoye Y Olukotun in ARWR
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
$174K2,000 sh × $86.96
Exec Aug 18
Filed Aug 20 · 5:25 PM ET